The Size of the Latin America Digital Breast Tomosynthesis (DBT) Equipment market size is valued at USD 159.59 million in 2022 and is expected to grow at a CAGR of 13.7% to reach USD 303.25 million by 2027 during the forecast period 2022 to 2027.
Digital breast tomosynthesis is a limited-angle tomography technology that uses X-rays to create a 3-dimensional image of the breast. It is a new technique that aids in identifying breast cancer in its early stages.
Another vital feature is digital breast tomosynthesis, which is particularly beneficial in analyzing dense breasts and can help improve and increase breast cancer detection. It lowers the rate of false-positive results when normal tissue is misidentified as abnormal and eliminates the necessity for a biopsy. It is suitable for any woman, but it is perfect for those with dense breasts.
The rising prevalence of breast cancer would significantly drive the Latin America digital breast tomosynthesis (DBT) Equipment market. According to statistics, women in Mexico will be diagnosed with 268,600 new instances of invasive breast cancer and 62,930 new cases of non-invasive breast cancer in 2019.
Furthermore, more than 150,000 breast cancer survivors in Brazil live with metastatic disease, with three-quarters of them being diagnosed with stage I-III. The rising prevalence of breast cancer in Latin America, raising awareness of the usage of tomosynthesis, and technological improvements in developing new novel imaging products are the primary drivers driving the digital breast tomosynthesis equipment market.
The lack of data on DBT's usefulness is expected to hamper the expansion of the global digital breast tomosynthesis (DBT) Equipment market. There have been no significant trials conducted on DBT. These trials require a large participant pool to show that DBT has a meaningful effect on cancer diagnosis.
The market's growth is also hampered by strict training requirements for radiologists and technicians.
Due to the desire for novel goods, rising screening uptake, and the availability of qualified healthcare professionals in this area, Latin America holds a moderate market share in the worldwide digital breast tomosynthesis (DBT) Equipment market.
This research report on the Latin America Digital Breast Tomosynthesis (DBT) Equipment Market has been segmented and sub-segmented into the following categories
By Product:
By End User:
By Country:
Geographically, the Latin America accounted for 55.1 percent of the global digital breast tomosynthesis (DBT) equipment market in terms of value in 2019. During DBT, patients are exposed to more radiation than during 2D mammography.
The Mexico digital breast tomosynthesis equipment market has major growth due to the female breast cancer accounts for 15% of all new cancer cases. In addition, technical improvements in breast imaging, well-established healthcare infrastructure, and rising healthcare spending contribute to the overall regional market's growth.
The Brazil digital breast tomosynthesis equipment market should expect favorable development prospects as radiation exposure is reduced. In addition, DBT's application in group and individual breast cancer screening and its usage in breast cancer detection and staging multiple lesions may be described by regulatory authorities.
KEY MARKET PLAYERS
Noteworthy Companies leading the Latin America Digital Breast Tomosynthesis (DBT) Equipment Market Profiled in the Report are Hologic Inc., Siemens Healthineers, Fujifilm Corporation. Other players in the market include GE Healthcare, Internazionale Medico Scientifica S.r.l. and Planmed Oy.,
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region